Previous 10 | Next 10 |
MINNEAPOLIS, Oct. 19, 2022 (GLOBE NEWSWIRE) -- Continuing its commitment to expanding access to life-saving ultrafiltration therapies for adult and pediatric patients suffering from fluid overload, Nuwellis, Inc. (Nasdaq: NUWE) today announced the appointment of Lynn Blake as Chief ...
MINNEAPOLIS, Oct. 18, 2022 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) ("Nuwellis" or the "Company"), a commercial-stage company focused on transforming the lives of people with fluid overload, today announced the closing of an underwritten public offering of units with gross proceeds...
Nuwellis ( NASDAQ: NUWE ) shares fell ~38% premarket on Friday after the company priced its $9.6M underwritten public offering of units. The offering includes 15,235,196 Class A units, offered at a price of $0.25/unit, and 23,157,124 Class B Units, offered at $0.25/unit....
MINNEAPOLIS, Oct. 14, 2022 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) (“Nuwellis” or the “Company”), a commercial-stage company focused on transforming the lives of people with fluid overload, today announced the pricing of an underwritten public offering ...
MINNEAPOLIS, Oct. 03, 2022 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a commercial-stage company focused on transforming the lives of people with fluid overload, today announced the results of the AVOID-HF clinical study analysis presented at the Heart Failure Society of America...
MINNEAPOLIS, Sept. 27, 2022 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a commercial-stage company focused on transforming the lives of people with fluid overload, today announced the activation of three additional sites for its pivotal REVERSE-HF (Ultrafiltration Versus IV Diuretics...
Nuwellis, Inc (NASDAQ: NUWE) has reported the publication of key clinical data supporting the use of ultrafiltration with the Aquadex FlexFlow system in high-risk postoperative coronary artery bypass grafting patients in the Journal of Cardiac Surgery. The study, “...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips In a fresh news release, Nuwellis (NASDAQ: NUWE ) announced encouraging clinical data related to proprietary technology that could be deployed in cardiac surgery. The results were released in the Journal of Cardiac...
Penny stocks are shares of companies trading for less than $5 and are some of the most volatile in the stock market today. Thanks to last week’s Jackson Hole speech from Fed Chair Jerome Powell, investors are on the hunt for new trade ideas. When it comes to stocks under $5, ther...
Nuwellis ( NASDAQ: NUWE ) surged 90% premarket after the company announced clinical data supporting the use of ultrafiltration with the Aquadex FlexFlow System in high-risk postoperative coronary artery bypass grafting patients. A total of 254 coronary artery bypa...
News, Short Squeeze, Breakout and More Instantly...
MINNEAPOLIS, July 23, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, today announced that it will release financial results for the second quarter of 2024 on Tuesday, August 13, 2024. Nuwellis w...
MINNEAPOLIS, July 17, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company dedicated to transforming the lives of patients suffering from fluid overload, is proud to announce its first commercial sale of QUELIMMUNE™, a novel therapy developed by SeaS...
DENVER, July 12, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU) (SeaStar Medical) reports the initial commercial sale of QUELIMMUNE ™ -Pediatric to its U.S. license and distribution partner, Nuwellis, Inc. QUELIMMUNE is SeaStar Medical’s Sel...